Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
Price:
8.02
CNY
-0.62%
Market Closed
Market Cap:
¥3.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
|
CN |
|
K
|
Kid ASA
OSE:KID
|
NO |
|
Physicians Realty Trust
NYSE:DOC
|
US |
|
G
|
Global Environmental Energy Corp
OTC:GEECF
|
BS |
|
W
|
Wealthfront Corp
NASDAQ:WLTH
|
US |
|
L
|
Leaders Cosmetics Co Ltd
KOSDAQ:016100
|
KR |
|
S
|
Solwers Oyj
OMXH:SOLWERS
|
FI |
|
A
|
Amazon.com Inc
XHAM:AMZ
|
US |
|
A
|
Attica Publications SA
ATHEX:ATEK
|
GR |
|
Tiziana Life Sciences Ltd
NASDAQ:TLSA
|
UK |
|
A
|
Anthem Biosciences Ltd
NSE:ANTHEM
|
IN |
|
Aker Carbon Capture ASA
OTC:AKCCF
|
NO |
|
S
|
Song Da Consulting JSC
VN:SDC
|
VN |
|
Digitiliti Inc
OTC:DIGI
|
US |
|
N
|
Nissan Motor Co Ltd
XHAM:NISA
|
JP |
|
S
|
SAI.TECH Global Corp
NASDAQ:SAI
|
US |
Multiples-Based Value
The Multiples-Based Value of one
Hainan Shuangcheng Pharmaceuticals Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 8.02 CNY,
Hainan Shuangcheng Pharmaceuticals Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hainan Shuangcheng Pharmaceuticals Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Hainan Shuangcheng Pharmaceuticals Co Ltd Competitors
Hainan Shuangcheng Pharmaceuticals Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Hainan Shuangcheng Pharmaceuticals Co Ltd
SZSE:002693
|
3.3B CNY | 15.4 | -77.4 | -79.5 | -79.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
902.5B USD | 13.6 | 43.1 | 29.1 | 31 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
581.1B USD | 6.1 | 21.5 | 15 | 18.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236.9B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.6 | 11.6 | 13 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
303.6B USD | 4.6 | 16.5 | 10.2 | 12.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
234.4B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 19.8 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.7B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
